EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Role of Chinese Medicine Monomers in Dry Eye Disease: Breaking the Vicious Cycle of Inflammation

Zhuoyu Hu, Xiangdong Chen iD, Qi Hu, Menglong Zou, Zhimin Liu

Pharmacology Research & Perspectives · 2025

DOI: 10.1002/prp2.70077 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacology Research & Perspectives, 2025. Verfasst von Zhuoyu Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Inflammation, Drugs, Chinese Herbal, Anti-Inflammatory Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hunan Provincial Clinical Medical Research Center for Ophthalmic Diseases (Traditional Chinese Medicine), Foundation for Innovative Research Groups of the National Natural Science Foundation of China, the Natural Science Foundation of Hunan Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dry eye disease (DED) is a chronically inflammatory ocular surface disorder of unknown pathogenesis. Anti‐inflammatory medications, artificial tears, autologous serum, and LipiFlow have been shown to be highly beneficial in alleviating symptoms. Nevertheless, these interventions often provide only short‐term results and do not address the underlying problems of the disease. There is growing evidence that the risk of DED is associated with a vicious cycle of inflammation. This vicious cycle of inflammation is produced by the interaction of several factors, including tear film hyperosmolarity, tear film instability, inflammation, and apoptosis. Chinese medicine monomers, distinguished by their multicomponent and multitarget advantages, have been shown to help treat DED by modulating tear film status, and inhibiting inflammatory responses, and apoptosis, providing a new way of thinking of the management of DED in Chinese medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dry Eye SyndromesInflammationDrugs, Chinese HerbalAnti-Inflammatory AgentsHumansAnimalsTearsApoptosisMedicine, Chinese Traditional

Stichwörter der Autor:innen

Chinese medicine monomerapoptosisdry eye diseaseinflammationvicious cycle

Substanzen

Drugs, Chinese HerbalAnti-Inflammatory Agents

Autor:innen und Institutionen

  • The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
  • Graduate School of Hunan University of Chinese Medicine, Changsha, Hunan, China.

ORCID-Profile: Xiangdong Chen

Förderung

  • Hunan Provincial Clinical Medical Research Center for Ophthalmic Diseases (Traditional Chinese Medicine)
  • Foundation for Innovative Research Groups of the National Natural Science Foundation of China
  • the Natural Science Foundation of Hunan Province of China
  • the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine(Inheritance and Innovation Project)
  • The key research project of Hunan Provincial Administration of Traditional Chinese Medicine
  • The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine (Advantageous Disease)
  • The Scientific Research Foundation of Hunan Provincial Department of Education
  • The Innovation Project for Graduate Students of Hunan University of Chinese Medicine.

Zitieren

APA

Hu, Z., Chen, X., Hu, Q., Zou, M., & Liu, Z. (2025). Role of Chinese Medicine Monomers in Dry Eye Disease: Breaking the Vicious Cycle of Inflammation. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70077

Vancouver

Hu Z, Chen X, Hu Q, Zou M, Liu Z. Role of Chinese Medicine Monomers in Dry Eye Disease: Breaking the Vicious Cycle of Inflammation. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70077

BibTeX
@article{Hu2025,
  author = {Hu, Zhuoyu and Chen, Xiangdong and Hu, Qi and Zou, Menglong and Liu, Zhimin},
  title = {Role of Chinese Medicine Monomers in Dry Eye Disease: Breaking the Vicious Cycle of Inflammation},
  journal = {Pharmacology Research & Perspectives},
  year = {2025},
  doi = {10.1002/prp2.70077}
}
Kostenlos starten →